Page last updated: 2024-10-23

bisoprolol and Substance Withdrawal Syndrome

bisoprolol has been researched along with Substance Withdrawal Syndrome in 2 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol."3.79[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome]. ( Arabadzisz, H; Jávor, K; Sármán, B; Tomcsányi, J; Wagner, V; Zsoldos, A, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bezgin, T1
Elveran, A1
Doğan, C1
Canga, Y1
Karagöz, A1
Esen, AM1
Tomcsányi, J1
Jávor, K1
Arabadzisz, H1
Zsoldos, A1
Wagner, V1
Sármán, B1

Other Studies

2 other studies available for bisoprolol and Substance Withdrawal Syndrome

ArticleYear
Takotsubo cardiomyopathy after bisoprolol withdrawal and open appendectomy.
    Herz, 2014, Volume: 39, Issue:3

    Topics: Antihypertensive Agents; Appendectomy; Bisoprolol; Diagnosis, Differential; Female; Humans; Middle A

2014
[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
    Orvosi hetilap, 2013, Feb-17, Volume: 154, Issue:7

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting En

2013